NCT03183804View on ClinicalTrials.gov

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

December 29, 2015

Primary Completion Date

August 17, 2018

Study Completion Date

October 24, 2018

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to diabetic foot ulcer. This study is a follow-up study without intervention.

OTHER

Standard therapy

Standard therapy conducted for patients with diabetic foot ulcer. This study is a follow-up study without intervention.

Trial Locations (4)

01830

Eulji General Hospital, Seoul

03722

Severance Hospital, Seoul

05505

Asan medical center, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT03183804 - A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial | Biotech Hunter | Biotech Hunter